Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HE7I
|
|||
| Former ID |
DIB005914
|
|||
| Drug Name |
H1N1 influenza vaccine
|
|||
| Synonyms |
Humenza; H1N1 influenza vaccine (AF-03-adjuvanted, EU market); H1N1 influenza vaccine (AF-03-adjuvanted, EU market), Sanofi Pasteur
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 3 | [1] | |
| Company |
Sanofi Pasteur
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell mediated immunity response (CMIR) | Target Info | . | [2], [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Sanofi Pasteur. | |||
| REF 2 | Clinical pipeline report, company report or official report of Sanofi Pasteur. | |||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.